Skip to content

STUDY TO EVALUATE THE EFFICACY OF AVALGUJADI LEPA AND VAYASYADI LEPA ALONG WITH LODRASAVA IN THE MANAGEMENT OF SHWITRA VIS-A-VIS VITILIGO

A RANDOMIZED DOUBLE ARM COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF AVALGUJADI LEPA AND VAYASYADI LEPA ALONG WITH LODRASAVA IN THE MANAGEMENT OF SHWITRA VIS-A-VIS VITILIGO - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094689
Enrollment
40
Registered
2025-09-12
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

None listed

Sponsors

Dr Tejaswini Lohar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Subjects presenting with the clinical features of Shwitra(Vitiligo). 2) Subjects of either gender between age group of 15-60 years. 3) Subjects with single or less than 5 localised white patches having surface area less than 6 sq.cm.will be selected. 4) Subjects with history of not more than one year of onset.

Exclusion criteria

Exclusion criteria: 1) Subjects having patch over the sites like lips, glans penis, ear lobes and nail bed. 2) Subjects associated with Leucoderma, albinism and other skin diseases. 3) Subjects suffering from systemic disorders like uncontrolled Diabetes Mellitus, HIV, HBsAg positive. 4) Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
SUBJECTIVE PARAMETERS 1. Daha (Burning sensation) OBJECTIVE PARAMETERS Objective parameters are taken based on the Vitiligo Extent Tensity Index score 1. Colour of patch 2. Size of patch 3. Number of patchTimepoint: 30 days

Secondary

MeasureTime frame
SUBJECTIVE PARAMETERS 1. Daha (Burning sensation) OBJECTIVE PARAMETERS Objective parameters are taken based on the Vitiligo Extent Tensity Index score 1. Colour of patch 2. Size of patch 3. Number of patchTimepoint: 30 days

Countries

India

Contacts

Public ContactDr Tejaswini Lohar

Ayurveda Mahavidyalaya and Hospital, Hubballi

madhukaya4@gmail.com7259348870

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026